Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon

ClinicalTrials.gov ID: NCT00577304

Public ClinicalTrials.gov record NCT00577304. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study of a Topical Formulation of Nitroglycerin, MQX-503, and Matching Vehicle in the Treatment and Prevention of Raynaud's Phenomenon

Study identification

NCT ID
NCT00577304
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
MediQuest Therapeutics
Industry
Enrollment
200 participants

Conditions and interventions

Eligibility (public fields only)

Age range
15 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2007
Primary completion
Feb 29, 2008
Completion
Feb 29, 2008
Last update posted
Feb 4, 2010

2007 – 2008

United States locations

U.S. sites
17
U.S. states
16
U.S. cities
17
Facility City State ZIP Site status
Stanford University Stanford California 94305
University of Colorado Health Sciences Center Denver Colorado 80045
University of Connecticut Farmington Connecticut 06030
Georgetown University Washington D.C. District of Columbia 20007
University of Chicago Chicago Illinois 60637
Johns Hopkins University Baltimore Maryland 21224
Boston University Boston Massachusetts 02118
Arthritis Education and Treatment Center, PLLC Grand Rapids Michigan 49546
University of Minnesota Minneapolis Minnesota 55455
University of Medicine and Dentistry of New Jersey New Brunswick New Jersey 08093
The Center for Rheumatology Albany New York 12206
SUNY Stony Brook Stony Brook New York 11794
Carolina Arthritis Wilmington North Carolina 28401
University of Toledo Toledo Ohio 43614
Medical University of South Carolina Charleston South Carolina 29425
University of Texas at Houston Houston Texas 77030
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00577304, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 4, 2010 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00577304 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →